New product licenses totals 684 in first half

The Korea Food and Drug Administration announced that licenses for new products in the first half of this year totaled 684, thanks to surging trend in the number of newly-tested bioequivalence items. Of the licenses, locally manufactured drugs accounted for 91 percent to 627 and imported drugs for nine percent to 57.

The administration further noted that in contrast with 595 ethic...